跳至主要内容
临床试验/CTRI/2022/04/042071
CTRI/2022/04/042071尚未招募未知

Clinical utility of adjuvant ketamine in first episode depression- a double blind, placebo controlled study

Ahana Hospitals LLP0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
尚未招募

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Participants willing to sign a written informed consent document;
  • Participants must fulfill ICD criteria for Depressive episode , with the severity being moderate to severe
  • Participants must be medically and neurologically healthy.

排除标准

  • Those who have neurological disorders, severe medical illness, mental retardation and co-morbid psychiatric diagnoses
  • Women who are pregnancy or breastfeeding
  • Those who are allergic to ketamine

研究者

相似试验